Global News and Digital Insights
for the Healthcare Industry

Satellite Bio to reveal bioengineering-based technology to restore organ function

Satellite Bio, a biotech startup, embarks on a challenging enterprise of working on a technology that restores organs by bioengineering tissues. Satellite Bio is ready to finance this particular regenerative therapy with $110 million. The organisation claims that the said technology will work on almost any type of cell. The startup aims to bioengineer tissues that will restore, mend, or replace a less functional organ. The model demonstrates how this approach will be different and workable than the previous experiments conducted for organ function restoration.

Read More from MedCityNews

Share on facebook
Share on twitter
Share on linkedin